Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tom Würdinger"'
Autor:
Jantine Geertruida Röttgering, Linda Douw, Philip C. de Witt Hamer, Mathilde C. M. Kouwenhoven, Tom Würdinger, Peter M. van de Ven, Louise Sharpe, Hans Knoop, Martin Klein
Publikováno v:
Trials, 23(1):568. BioMed Central
Röttgering, J G, Douw, L, de Witt Hamer, P C, Kouwenhoven, M C M, Würdinger, T, van de Ven, P M, Sharpe, L, Knoop, H & Klein, M 2022, ' Reducing severe fatigue in patients with diffuse glioma : a study protocol for an RCT on the effect of blended cognitive behavioural therapy ', Trials, vol. 23, no. 1, 568, pp. 568 . https://doi.org/10.1186/s13063-022-06485-5
Röttgering, J G, Douw, L, de Witt Hamer, P C, Kouwenhoven, M C M, Würdinger, T, van de Ven, P M, Sharpe, L, Knoop, H & Klein, M 2022, ' Reducing severe fatigue in patients with diffuse glioma : a study protocol for an RCT on the effect of blended cognitive behavioural therapy ', Trials, vol. 23, no. 1, 568, pp. 568 . https://doi.org/10.1186/s13063-022-06485-5
Background Fatigue is the most frequent and burdensome symptom of patients with diffuse glioma. It is closely linked to decreased health-related quality of life and symptoms such as depression and sleep disturbances. Currently, there is no evidence-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa100e5f8d579883afd4d5084fc5f31
https://research.vumc.nl/en/publications/a5f1070e-d49c-4c05-95a6-71f5a0db8a23
https://research.vumc.nl/en/publications/a5f1070e-d49c-4c05-95a6-71f5a0db8a23
Autor:
Walter Ageno, Marc Carrier, Patrick M.M. Bossuyt, Myron G. Best, Marcello Di Nisio, Frederikus A. Klokm, Mike J L Peters, Marije ten Wolde, Yassene Mohammed, Pieter Willem Kamphuisen, Thomas Wurdinger, Noémie Kraaijpoel, Benilde Cosmi, Frits I. Mulder, Annabel van Lieshout, Nick van Es, Jan Beyer-Westendorf, Hans-Martin Otten, Bart J.M. van Vlijmen, Luis Jara-Palomares, Harry R. Büller, Thomas Vanassche
Publikováno v:
Thrombosis Update, 2:100030. Elsevier BV
Thrombosis Update, Vol 2, Iss, Pp 100030-(2021)
Kraaijpoel, N, Mulder, F I, Carrier, M, van Lieshout, A, Würdinger, T, Best, M G, van Vlijmen, B J M, Mohammed, Y, Jara-Palomares, L, Kamphuisen, P W, di Nisio, M, Ageno, W, Beyer-Westendorf, J, Vanassche, T, Klokm, F A, Otten, H-M, Peters, M J L, Cosmi, B, Wolde, M T, Bossuyt, P M M, Büller, H R & van Es, N 2021, ' Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism : Rationale and design of the PLATO-VTE study ', Thrombosis Update, vol. 2, 100030 . https://doi.org/10.1016/j.tru.2020.100030
Thrombosis Update, Vol 2, Iss, Pp 100030-(2021)
Kraaijpoel, N, Mulder, F I, Carrier, M, van Lieshout, A, Würdinger, T, Best, M G, van Vlijmen, B J M, Mohammed, Y, Jara-Palomares, L, Kamphuisen, P W, di Nisio, M, Ageno, W, Beyer-Westendorf, J, Vanassche, T, Klokm, F A, Otten, H-M, Peters, M J L, Cosmi, B, Wolde, M T, Bossuyt, P M M, Büller, H R & van Es, N 2021, ' Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism : Rationale and design of the PLATO-VTE study ', Thrombosis Update, vol. 2, 100030 . https://doi.org/10.1016/j.tru.2020.100030
Occult cancer is detected in about 5% of patients with unprovoked venous thromboembolism (VTE) in the 12 months following VTE diagnosis. Current guidance suggests conducting a ‘limited’ cancer screening in these patients, consisting of medical hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232df4c971368cc3a7124920055a7d38
https://hdl.handle.net/11383/2151173
https://hdl.handle.net/11383/2151173